Treatment of Resistant Hypertension

Foundation Three-Drug Regimen

The American Diabetes Association recommends starting with a long-acting thiazide-like diuretic, such as chlorthalidone 12.5-25 mg or indapamide 1.25-2.5 mg daily, which are superior to hydrochlorothiazide for 24-hour blood pressure control and are preferred agents for cardiovascular event reduction in diabetes 3, 2
The American Heart Association suggests adding a dihydropyridine calcium channel blocker, such as amlodipine 5-10 mg daily, which is metabolically neutral and does not worsen insulin resistance, making it ideal for patients with diabetes and insulin resistance 3, 2
The American College of Cardiology recommends including an ACE inhibitor or ARB at maximum tolerated dose as the third agent, which is particularly important in diabetic patients as these agents improve insulin sensitivity, provide renal protection, and reduce cardiovascular events 3, 2

The European Society of Cardiology suggests adding spironolactone 25 mg daily as the most effective fourth-line agent for resistant hypertension, which reduces office systolic BP by 13.3 mmHg and 24-hour systolic BP by 8.5 mmHg 1, 2, 5
The American Heart Association recommends titrating spironolactone to 50 mg daily if blood pressure remains uncontrolled after 2-4 weeks and the patient tolerates the initial dose without hyperkalemia 1, 5

The American Diabetes Association recommends monitoring serum potassium and creatinine 1-2 weeks after initiating spironolactone, then at least quarterly, as combining a mineralocorticoid receptor antagonist with an ACE inhibitor or ARB significantly increases hyperkalemia risk 3, 1, 5
The European Society of Cardiology suggests performing 24-hour ambulatory blood pressure monitoring to confirm true resistant hypertension and exclude white-coat hypertension before escalating therapy 2, 5

The American Heart Association recommends restricting dietary sodium to less than 2,300 mg/day, which can reduce systolic/diastolic BP by 5-10/2-6 mmHg, with greater benefit in diabetic patients 3, 4, 2
The American College of Cardiology suggests achieving weight loss if overweight or obese, as a 10-kg weight loss reduces systolic BP by 6.0 mmHg and diastolic BP by 4.6 mmHg 4, 2

The American Diabetes Association recommends never combining an ACE inhibitor with an ARB, as this combination increases adverse events without additional cardiovascular benefit 3, 1

The European Society of Cardiology suggests addressing medication non-adherence, which accounts for approximately 50% of apparent treatment resistance, by simplifying regimens and considering home blood pressure monitoring to improve adherence 4, 1, 2

The American Diabetes Association recommends a target blood pressure of <140/90 mmHg for most patients with diabetes, though individualized targets may be appropriate based on age and comorbidities 3